Unicycive Therapeutics Inc (UNCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,887 | -5,877 | 570 | -36,729 | -15,204 |
| Depreciation Amortization | 421 | 273 | 135 | 428 | 294 |
| Other Working Capital | -3,894 | -4,131 | -1,823 | -427 | -2,129 |
| Other Operating Activity | -7,925 | -7,588 | -7,785 | 8,153 | -4,988 |
| Operating Cash Flow | $-23,285 | $-17,323 | $-8,903 | $-28,575 | $-22,027 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24 | -22 | -16 | -72 | -50 |
| Investing Cash Flow | $-24 | $-22 | $-16 | $-72 | $-50 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -212 | -211 | -160 | -527 | -369 |
| Common Stock Issued | 41,267 | 14,120 | -84 | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | -1,095 | -1,095 |
| Other Financing Activity | -1,193 | -379 | 2,790 | 46,710 | 46,187 |
| Financing Cash Flow | $39,862 | $13,530 | $2,546 | $45,088 | $44,723 |
| Beginning Cash Position | 26,142 | 26,142 | 26,142 | 9,701 | 9,701 |
| End Cash Position | 42,695 | 22,327 | 19,769 | 26,142 | 32,347 |
| Net Cash Flow | $16,553 | $-3,815 | $-6,373 | $16,441 | $22,646 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,285 | -17,323 | -8,903 | -28,575 | -22,027 |
| Capital Expenditure | -24 | -22 | -16 | -72 | -50 |
| Free Cash Flow | -23,309 | -17,345 | -8,919 | -28,647 | -22,077 |